Real-life data of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in the patients with chronic hepatitis B: a single-center experience

Mustafa AKAR

doi:10.38053/acmj.951923

Real-life data of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in the patients with chronic hepatitis B: a single-center experience

Anatolian Current Medical Journal ◽

10.38053/acmj.951923 ◽

2021 ◽

Vol 3 (3) ◽

pp. 239-245

Author(s):

Mustafa AKAR

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Single Center ◽

Life Data ◽

Single Center Experience ◽

Real Life Data ◽

Tenofovir Alafenamide

Download Full-text

Two-year Single-Center Real-Life Data of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B Patients in Taiwan

Journal of Gastroenterology and Hepatology Research ◽

10.17554/j.issn.2224-3992.2016.05.610 ◽

2016 ◽

Vol 5 (2) ◽

pp. 2010-2014

Author(s):

Shou-Wu Lee ◽

◽

Teng-Yu Lee ◽

Sheng-Shun Yang ◽

Hong-Zen Yeh ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Single Center ◽

Life Data ◽

Real Life Data

Download Full-text

Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience

Viral Hepatitis Journal ◽

10.4274/vhd.94830 ◽

2016 ◽

Vol 22 (3) ◽

pp. 92-96

Author(s):

Pınar KORKMAZ ◽

Figen ÇEVİK ÇAĞLAN ◽

Nevil AYKIN ◽

Hasan NAZ ◽

Onur TOKA

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Life Outcomes ◽

Single Center ◽

Single Center Experience

Download Full-text

Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B

Saudi Journal of Gastroenterology ◽

10.4103/sjg.sjg_49_18 ◽

2018 ◽

Vol 24 (6) ◽

pp. 326 ◽

Cited By ~ 11

Author(s):

HyunPhil Shin ◽

YoungMin Kim ◽

JoungIl Lee ◽

KwangRo Joo ◽

JaeMyung Cha ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Real World ◽

Tenofovir Disoproxil Fumarate ◽

Single Center ◽

Single Center Experience ◽

Treatment Naïve

Download Full-text

Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients

Digestive and Liver Disease ◽

10.1016/j.dld.2019.12.108 ◽

2020 ◽

Vol 52 ◽

pp. e27

Author(s):

M. Viganò ◽

A. Loglio ◽

F. Cerini ◽

E. Farina ◽

F. Facchetti ◽

...

Keyword(s):

Bone Mineral Density ◽

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Bone Mineral ◽

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Mineral Density ◽

Caucasian Patients

Download Full-text

IDDF2018-ABS-0108 Improved bone and renal safety at 1 year after switching from TENOFOVIR DISOPROXIL FUMARATE (TDF) to TENOFOVIR ALAFENAMIDE (TAF): results from 2 phase 3 studies in HBEAG-positive and HBEAG-negative patients with chronic hepatitis B (CHB)

10.1136/gutjnl-2018-iddfabstracts.209 ◽

2018 ◽

Cited By ~ 1

Author(s):

Henry Lek-Yuen Chan ◽

Calvin Pan ◽

Maurizia Brunetto ◽

Aric Josun Hui ◽

Rajiv Mehta ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Phase 3 ◽

Tenofovir Alafenamide ◽

Renal Safety

Download Full-text

Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide

Journal of Viral Hepatitis ◽

10.1111/jvh.13053 ◽

2019 ◽

Vol 26 (5) ◽

pp. 561-567 ◽

Cited By ~ 9

Author(s):

Tse‐Ling Fong ◽

Brian T. Lee ◽

Andy Tien ◽

Mimi Chang ◽

Carolina Lim ◽

...

Keyword(s):

Bone Mineral Density ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Bone Mineral ◽

Tenofovir Disoproxil Fumarate ◽

Mineral Density ◽

Renal Tubular Function ◽

Tenofovir Alafenamide ◽

Renal Tubular

Download Full-text

IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

10.1136/gutjnl-2019-iddfabstracts.278 ◽

2019 ◽

Author(s):

Henry Lik Yuen Chan ◽

Pietro Lampertico ◽

Maria Buti ◽

Scott Fung ◽

Sang Hoon Ahn ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide

Download Full-text

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature

Hematology ◽

10.1080/10245332.2017.1385193 ◽

2017 ◽

Vol 23 (4) ◽

pp. 212-220 ◽

Cited By ~ 5

Author(s):

Seniz Ongoren ◽

Ahmet Emre Eskazan ◽

Veysel Suzan ◽

Sercan Savci ◽

Isil Erdogan Ozunal ◽

...

Keyword(s):

Myeloid Leukemia ◽

Kinase Inhibitors ◽

Real Life ◽

Review Of The Literature ◽

Single Center ◽

Life Data ◽

Single Center Experience ◽

Real Life Data ◽

Third Line ◽

Third Line Treatment

Download Full-text

Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Negative, Chronic Hepatitis B Patients: A Global Phase 3 Study

Gastroenterology ◽

10.1016/s0016-5085(17)33661-2 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1086

Author(s):

Maurizia Rossana Brunetto ◽

Young-Suk Lim ◽

Edward Gane ◽

Wai-Kay Seto ◽

Marina Osipenko ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide ◽

Negative Chronic Hepatitis

Download Full-text

Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Positive Patients: A Global Phase 3 Study

Gastroenterology ◽

10.1016/s0016-5085(17)33660-0 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1085-S1086

Author(s):

Kosh Agarwal ◽

Scott Fung ◽

Wai-Kay Seto ◽

Young-Suk Lim ◽

Edward Gane ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide

Download Full-text